Role of sigma 1 receptor in retinal degeneration of the Ins2Akita/+ murine model of diabetic retinopathy
- ,
- Xuezhi Cui,
- Penny Roon,
- Sylvia B. Smith(corresponding author)
- ,
- Augusta University
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Purpose: Sigma receptor 1 (Sigma1R), a nonopioid putative molecular chaperone, has neuroprotective properties in retina. This study sought to determine whether delaying administration of (+)-pentazocine, a high-affinity Sigma1R ligand after onset of diabetes in Ins2<sup>Akita/+</sup> diabetic mice would afford retinal neuroprotection and to determine consequences on retinal phenotype in Ins2<sup>Akita/+</sup> diabetic mice in the absence of Sigma1R. Methods: Ins2<sup>Akita/+</sup> diabetic and WT mice received intraperitoneal injections of (+)-pentazocine beginning 4 or 8 weeks after onset of diabetes; eyes were harvested at 25 weeks. Retinal histologic sections were analyzed to determine thicknesses of retinal layers, number of ganglion cells, and evidence of gliosis (increased glial fibrillary acidic protein levels). Ins2<sup>Akita/+</sup>/Sig1R<sup>−/−</sup>mice were generated and subjected to in vivo assessment of retinal architecture (optical coherence tomography [OCT]) and retinal vasculature using fluorescein angiography (FA) at 12 and 16 weeks compared with age-matched Ins2<sup>Akita/+</sup> mice. Eyes were then harvested for retinal morphometric assessment and gliosis assessment. Results: Wild-type mice had 13 ± 0.06 cells/100 μm retinal length; cell bodies in Ins2<sup>Akita/+</sup> mice injected 4 and 8 weeks after onset of diabetes with (+)-pentazocine retained significantly more ganglion cells compared with Ins2<sup>Akita/+</sup> mice (9 ± 0.04) and demonstrated significant attenuation of gliosis. Ins2<sup>Akita/+</sup>/Sig1R<sup>−/−</sup>mouse retinas, analyzed to determine whether the Ins2<sup>Akita/+</sup> phenotype was accelerated when lacking Sigma1R, revealed increased nerve fiber layer thickness (OCT), evidence of vitreal opacities, and vessel beading (FA) compared with Ins2<sup>Akita/+</sup> mice. Morphometric analysis revealed significantly fewer ganglion cells in Ins2<sup>Akita/+</sup>/Sig1R<sup>−/−</sup>mice compared with Ins2<sup>Akita/+</sup> mice. Conclusions: Sigma1R may be a novel retinal stress modulator, and targeting it even after disease onset may afford retinal neuroprotection.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 2770-2781 (12 pages)Journal (Volume, Issue Number)
Investigative Ophthalmology and Visual Science (Volume 57, Issue 6)Publication milestones
- Published - 05/01/2016
Publication status
Published - 05/01/2016
ISSN
0146-0404Publication IDs
- Scopus: 84969983950
- PubMed: 27206247
Publication metrics
Metrics
SciVal
FWCI
0.50
SciVal
Author count
4
SciVal
citations
7
SciVal
Paper percentile
64
Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Citation count
20
Captures
37
Funding Details
Supported by National Institutes of Health Grant R01 EY014560 and the James and Jean Culver Vision Discovery Institute.
FundersFunding numbers
NIH
R01 EY014560
NEI
R21EY013089
James and Jean Culver Vision Discovery Institute, Georgia Regents University
-